Veterinary Biologics Global Market Report 2024

Description

Veterinary biologics encompass biological products obtained from living organisms such as viruses, bacteria, or other microorganisms. These specialized products in veterinary medicine serve to prevent, diagnose, or treat diseases in animals.

Key products falling under veterinary biologics include vaccines, diagnostic kits, immunomodulators, antiserums, antibodies, and related items. Vaccines, for instance, are formulated to trigger the immune system's response and offer protection against specific animal diseases. They address various ailments such as bluetongue, foot and mouth disease, brucellosis, tuberculosis, and others. These products are distributed through multiple channels, including veterinary hospitals and clinics, for diverse applications involving both production and companion animals.

The veterinary biologics market research report is one of a series of new reports from The Business Research Company that provides veterinary biologics market statistics, including veterinary biologics industry global market size, regional shares, competitors with a veterinary biologics market share, detailed veterinary biologics market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary biologics industry. This veterinary biologics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary biologics market size has grown strongly in recent years. It will grow from $11.77 billion in 2023 to $12.78 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth observed in the historic period can be linked to several factors. These include occurrences of animal disease outbreaks, supportive regulatory frameworks and standards, an increasing emphasis on food safety, the globalization of trade, and the substantial economic importance placed on livestock.

The veterinary biologics market size is expected to see strong growth in the next few years. It will grow to $17.11 billion in 2028 at a compound annual growth rate (CAGR) of 7.6%. The anticipated growth in the forecast period can be tied to several factors, including the rise of emerging infectious diseases, changing disease patterns influenced by climate change, advancements in precision livestock farming, the adoption of a holistic One Health approach, and the increasing trend of pet ownership. Key trends expected in this period encompass education and training programs, the development of eco-friendly and sustainable biologics, integration of digital health records, a surge in companion animal biologics, and the proliferation of customized and targeted therapies.

The upsurge in the prevalence of animal diseases is anticipated to be a driving force behind the growth of the veterinary biologics market. Animal diseases encompass a range of illnesses affecting diverse animal species. The escalation in these diseases underscores the need for advanced diagnostic and treatment solutions, a demand met by veterinary biologics that employ immunological methods to address and manage animal diseases. As of October 2022, the European Center for Disease Prevention and Control reported 2,467 outbreaks of avian influenza in poultry, impacting 48 million birds, with an additional 187 cases observed in captive birds. In a related context, the World Health Organization disclosed in July 2022 that rabies claims the lives of 59,000 people annually across over 150 countries, with a predominant 95% of cases concentrated in Africa and Asia. This surge in animal diseases is a pivotal factor propelling the veterinary biologics market.

The increasing trend of pet adoption is poised to contribute significantly to the growth of the veterinary biologics market. Pet adoption involves assuming responsibility for a domesticated animal, often from shelters or rescue organizations, to provide a permanent and caring home. Veterinary biologics play a crucial role in preventing infectious diseases in pets, offering immunity, controlling zoonotic diseases, enhancing lifespan and quality of life, reducing veterinary healthcare costs, improving reproductive health in pets, and providing more targeted and customized treatment options. Data from October 2023, as reported by the American Pet Products Association, reveals that 66% of U.S. households, totaling 86.9 million, own a pet-an increase from 62% in 2022. This surge in pet adoption is a significant driver behind the expanding veterinary biologics market.

The trend of developing innovative biologics is gaining momentum in the veterinary biologics market, with major companies spearheading efforts in this direction. In March 2021, Elanco Animal Health Incorporated, a prominent U.S.-based veterinary pharmaceutical company, introduced Elura (capromorelin oral solution) to address weight loss in cats afflicted with chronic kidney diseases (CKD). Notably, Elura represents the inaugural ghrelin receptor agonist sanctioned by the U.S. Food and Drug Administration (FDA), utilizing a novel mechanism to combat weight loss in cats with CKD. This oral solution, characterized by a palatable taste and a minimal dosage, serves as a long-term treatment option introduced at the time of diagnosis, supporting cat owners in managing their animals through this ailment.

Companies at the forefront of the veterinary biologics market are also channeling their efforts into the creation of innovative products, such as injections designed to control pain associated with osteoarthritis (OA) in dogs. These injections target canine nerve growth factors, providing an effective means to alleviate the pain that dogs experience due to osteoarthritis. Zoetis Inc., a distinguished U.S.-based animal health company, secured approval from the U.S. Food and Drug Administration (FDA) for Librela (bedinvetmab injection) in May 2023. Positioned as the first and only monthly anti-NGF monoclonal antibody medication for canine OA pain, Librela stands out as a safe and efficacious solution for managing long-term OA pain symptoms in dogs. This approval underscores Librela's role in enhancing the mobility and overall well-being of canines grappling with osteoarthritis, contributing to an improved quality of life for these animals.

In August 2021, Elanco Animal Health Incorporated, a US-based animal health company, completed the acquisition of Kindred Biosciences for approximately $444 million. Through this strategic acquisition, Elanco aimed to strengthen its position in the dermatology market within the veterinary medicine sector. This acquisition enabled Elanco to not only cater more effectively to its current customer base but also expand its reach by attracting new clients. Kindred Biosciences, the acquired company, specializes in the development of biologics and advanced technologies for veterinary medicine.

Major companies operating in the veterinary biologics market report are Bayer AG, Eli Lilly & Company,Evonik Industries AG, Zoetis Inc., VCA Inc., Merck Animal Health Inc., Boehringer Ingelheim Animal Health Inc., Elanco Animal Health, IDEXX Laboratories Inc., Nutreco N.V., Virbac SA, Hologic Inc., Phibro Animal Health Corporation, Vetoquinol, Valneva, Abaxis Inc., Bimeda Biologicals, Ceva Sante Animale S.A., Heska Corporation, Heska Corporation, Colorado Serum Company, Hester Biosciences Limited, INDICAL Bioscience GmbH, Ambrx Biopharma Inc., Adamis Pharmaceuticals Corporation, Intervet Inc., Hebei Veyong Animal Pharmaceutical Co. Ltd.,FidoCure, Biomet Biologics LLC, CytoDyn Veterinary Medicine LLC, KM Biologics

North America was the largest region in the veterinary biologics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the veterinary biologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The veterinary biologics market consists of sales of transplant tissues, recombinant proteins, and stem cells. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Biologics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary biologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary biologics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary biologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Product: Vaccines; Diagnostic Kits; Immunomodulators; Antiserums And Antibodies; Other Products
2) By Disease Type: Bluetongue; Foot And Mouth Disease; Brucellosis And Tuberculosis; Other Diseases
3) By Distribution Channel: Veterinary Hospitals; Veterinary Clinics; Other Distribution Channels
4) By Application: Production Animal; Companion Animal
Companies Mentioned: Bayer AG; Eli Lilly & Company;Evonik Industries AG; Zoetis Inc.; VCA Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r13998

1. Executive Summary

2. Veterinary Biologics Market Characteristics

3. Veterinary Biologics Market Trends And Strategies

4. Veterinary Biologics Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Veterinary Biologics Market Size and Growth

5.1. Global Veterinary Biologics Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Veterinary Biologics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Veterinary Biologics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Veterinary Biologics Market Segmentation

6.1. Global Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Vaccines
Diagnostic Kits
Immunomodulators
Antiserums And Antibodies
Other Products
6.2. Global Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Bluetongue
Foot And Mouth Disease
Brucellosis And Tuberculosis
Other Diseases
6.3. Global Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Veterinary Hospitals
Veterinary Clinics
Other Distribution Channels
6.4. Global Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Production Animal
Companion Animal

7. Veterinary Biologics Market Regional And Country Analysis

7.1. Global Veterinary Biologics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Veterinary Biologics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Veterinary Biologics Market

8.1. Asia-Pacific Veterinary Biologics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Veterinary Biologics Market

9.1. China Veterinary Biologics Market Overview
9.2. China Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Veterinary Biologics Market

10.1. India Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Veterinary Biologics Market

11.1. Japan Veterinary Biologics Market Overview
11.2. Japan Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Veterinary Biologics Market

12.1. Australia Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Veterinary Biologics Market

13.1. Indonesia Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Veterinary Biologics Market

14.1. South Korea Veterinary Biologics Market Overview
14.2. South Korea Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Veterinary Biologics Market

15.1. Western Europe Veterinary Biologics Market Overview
15.2. Western Europe Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Veterinary Biologics Market

16.1. UK Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Veterinary Biologics Market

17.1. Germany Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Veterinary Biologics Market

18.1. France Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Veterinary Biologics Market

19.1. Italy Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Veterinary Biologics Market

20.1. Spain Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Veterinary Biologics Market

21.1. Eastern Europe Veterinary Biologics Market Overview
21.2. Eastern Europe Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Veterinary Biologics Market

22.1. Russia Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Veterinary Biologics Market

23.1. North America Veterinary Biologics Market Overview
23.2. North America Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Veterinary Biologics Market

24.1. USA Veterinary Biologics Market Overview
24.2. USA Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Veterinary Biologics Market

25.1. Canada Veterinary Biologics Market Overview
25.2. Canada Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Veterinary Biologics Market

26.1. South America Veterinary Biologics Market Overview
26.2. South America Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Veterinary Biologics Market

27.1. Brazil Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Veterinary Biologics Market

28.1. Middle East Veterinary Biologics Market Overview
28.2. Middle East Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Veterinary Biologics Market

29.1. Africa Veterinary Biologics Market Overview
29.2. Africa Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Veterinary Biologics Market Competitive Landscape And Company Profiles

30.1. Veterinary Biologics Market Competitive Landscape
30.2. Veterinary Biologics Market Company Profiles
- 30.2.1. Bayer AG
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Eli Lilly & Company
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Evonik Industries AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Zoetis Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. VCA Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Veterinary Biologics Market Other Major And Innovative Companies

31.1. Merck Animal Health Inc.
31.2. Boehringer Ingelheim Animal Health Inc.
31.3. Elanco Animal Health
31.4. IDEXX Laboratories Inc.
31.5. Nutreco N.V.
31.6. Virbac SA
31.7. Hologic Inc.
31.8. Phibro Animal Health Corporation
31.9. Vetoquinol
31.10. Valneva
31.11. Abaxis Inc.
31.12. Bimeda Biologicals
31.13. Ceva Sante Animale S.A.
31.14. Heska Corporation
31.15. Heska Corporation

32. Global Veterinary Biologics Market Competitive Benchmarking

33. Global Veterinary Biologics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Veterinary Biologics Market

35. Veterinary Biologics Market Future Outlook and Potential Analysis

35.1 Veterinary Biologics Market In 2028 - Countries Offering Most New Opportunities
35.2 Veterinary Biologics Market In 2028 - Segments Offering Most New Opportunities
35.3 Veterinary Biologics Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer